K Pharma Inc (4896) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	414.00M	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	231.00M	-186.00M	237.00M	234.00M
Operating expense	231.00M	248.00M	237.00M	234.00M
Total operating expenses	231.00M	248.00M	237.00M	234.00M
Operating income	-231.00M	-248.00M	-237.00M	-234.00M
Other non operating income	-	-1.00M	-1.00M	1.00M
EBT including unusual items	-236.00M	-312.00M	-250.00M	-241.00M
EBT excluding unusual items	-229.00M	-256.00M	-243.00M	-241.00M
Income tax expense	1.00M	-	-	1.00M
Effective tax rate	-0.42%	-	-	-0.41%
Other operating expenses	-	20.00M	-	-
Net income	-237.00M	-312.00M	-250.00M	-242.00M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	2.00M	-	2.00M	-
Interest expense	-	-7.00M	-7.00M	-8.00M
Net interest expenses	2.00M	-7.00M	-5.00M	-8.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance